ENTER THE MM&M AWARDS

The new deadline for entries is FRIDAY, JUNE 4. Ensure your work gets the recognition it deserves. Click here to submit your entry today and to check out this year's lineup of judges.

WEBCAST




Cegedim Relationship Management (formerly Cegedim Dendrite) provides pharmaceutical manufacturers with industry-leading products and services that help build market share and encourage medication adherence. Our products and services include our market-leading IntelliScript Co-pay 2.0 Platform, powerful SmartTools that optimize co-pay card performance, bi-directional CRM and Adherence programs, targeted Medical Communications, and actionable Marketing and Sales Analytics solutions. To learn more, visit our website at www.cegedimdendrite.com.

MM&M ON TWITTER



The Mobile Guide
Trends, data, insights and expert advice on the challenges and opportunities of using mobile to reach healthcare professionals and consumers

MM&M Service Directory Featured Company


MM&M Agency A-to-Z Survey 2011

Don't miss your chance to be a part our definitive annual directory of healthcare agencies! Deadline is June 8th.  For more information contact Ty Bartholomew at 646-638-6015 or ty.bartholomew@haymarketmedia.com.


SALARY SURVEY



 It's YOUR program, so YOU pick the color. Click here now to vote.

The Agency Gallery


SUBSCRIBE TO MM&M


MM&M offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

GSK awareness ad for Arzerra a stealth product promotion, says FDA

The FDA scolded GlaxoSmithKline over a disease-awareness ad that failed to mention side effects but alluded to newly approved cancer treatment Arzerra. It's a sign the agency is construing the exemption for disease-awareness promotions quite narrowly.
 

Global drug sales to grow 5%-8% through 2014 despite patent losses, says IMS

Global sales of pharmaceuticals will grow at a rate of 5%-8% annually over the next five years, IMS Health forecasts -- even as products with sales of more than $142 billion lose patent protection in top markets, reducing drug spending by $80-$100 billion.
 

GSK signed the most in-license drug deals in '08-'09

Of the top 10 pharma companies worldwide, GlaxoSmithKline looked beyond its own pipeline for new drugs most often, signing 67 in-licensing agreements in just two years, according to a Datamonitor analysis.
 

Concern over where ads appear online hindering spend, new whitepaper says

It is a problem that has plagued online advertising since 1994, when the first clickable banner ad appeared. Then, as now, ensuring the credibility of online ad platforms can be tricky, and that reality has marketers hesitant to fully allocate online media budgets.
 

FROM OUR SPONSORS


Modern Medicine
Whitepaper: Six Concepts for Engaging Physicians Online
We have brought together some recent posts from our new marketing blog into a free whitepaper where we share insights on engaging physicians and healthcare professionals online and the digital strategies to support that goal. Click Here to Download the Free Whitepaper


Best Practices for eDetailing: Self-Guided Interactive Video As physician media consumption shifts, eDetailing has emerged as an effective tool to address both the physician's need for information, as well as their time constraints. This best practices guide covers the latest techniques to create better learning experiences, improve information retention, create content that fuels data collection opportunities, and provide superior post-campaign analytics. Improve engagement and start delivering measurable results...download the guide now!


According to Nielsen, the #1 professional activity physicians do online is research drug information. #2 is reading medical journals. e-Healthcare Solutions represents the professional pages of Drugs.com plus JAMA, AFP, Annals, and numerous other specialty journals. Let us put your brand in front of doctors on the Internet.

In Brief

People News: Novartis

Novartis has named Andre Wyss to replace Ludwig Hantson as head of pharma for North America, The Wall Street Journal reported.
 

Company News: Johnson & Johnson, Lilly, Medicine Avenue Volume Two

Johnson & Johnson said sales for the first quarter were up just 4% to $15.6 billion, in line with Wall Street projections, while Eli Lilly reported first-quarter earnings of $1.18, beating analyst consensus by 8 cents, but lowered its guidance because of healthcare reform
 

LATEST FEATURES

DTC Report: Flat is the New Up

After a sharp downturn, consumer ad outlays have stabilized. Advertisers are spending again, but with budgets under pressure, they're seeking deals, and amid thinning pipelines, they're supporting mature blockbusters later in their lifecycles. Matthew Arnold reports on the trends
 

Journal Ad Review: Down But Not Out

The last thing medical/surgical journals needed was a recession. James Chase teams up with Kantar Media to chart the biggest advertisers and the most advertised categories and brands of '09
 

MM&M Therapeutic Focus: Vaccines

Seeking reliable franchises to support earnings, pharma has made vaccines a key part of the biologics portfolio. Marc Iskowitz scopes out the immunity boosting potential, how the main players maintain share of voice and what's next
 

Headliner: Pfizer vaccines chief Mark Swindell

Mark Swindell, president of Pfizer vaccines, began his career in 1983 in the finance department of Cyanamid, a mid-sized pharma company in the UK. Six years later the company gave him an opportunity to learn the sales side of the business.
 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.